Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs Inhalation Anesthesia in RCC Nephrectomy
NCT04503148Active, not recruiting
- Sponsor
- Seoul National University Hospital
- Start
- Sep 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of propofol injection (veterinary) in renal cell carcinoma (RCC) (2 arms), sponsored by Seoul National University Hospital. Primary endpoint: Five year metastasis-free survival at 5 years. Started Sep 2020; status: active, not recruiting.
02
Drugs
propofol injection (veterinary)
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT04503148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04503148.